SENORES PHARMACEUTICALS L (SENORES): Senores Pharmaceuticals Share Price Falls 6.02% to Rs 1,244.40 in Today's Trade

Updated: 29 Oct 2026 • 2:41 pm

Posted by:

SENORES PHARMACEUTICALS L (SENORES): Senores Pharmaceuticals Share Price Falls 6.02% to Rs 1,244.40 in Today's Trade

SENORES PHARMACEUTICALS L (SENORES) share price fell to Rs 1,244.4 today, down 6.02% from the previous close. Market cap was Rs 6,034.4 crore.

Senores Pharmaceuticals share price is under pressure today, with the stock last traded at Rs 1,244.40 as of 29 October 2026 at 2:37:47 PM IST. That is a fall of Rs 79.65, or 6.02%, from the previous close of Rs 1,324.05. The company, listed as SENORES and classed as a Mid Cap, carries a market capitalisation of Rs 6,034.40 crore.

This is a price fall in the latest session alone, not a multi-day slide. The stock opened at Rs 1,328.75, touched a high of Rs 1,339.50 and a low of Rs 1,228.25, and is now trading Rs 16.15 above that low. Univest data places the company in the Healthcare sector and the Pharmaceuticals and Drugs industry, where it is compared against 199 listed companies.

Readers following Senores Pharmaceuticals stock performance will find the key numbers below: a P/E ratio of 48.25, a P/B ratio of 6.33, ROE of 14.14%, ROCE of 15.66%, EPS of Rs 27.44 and book value of Rs 209.27 per share. The sections that follow cover the price action, fundamentals, sector benchmark, peer comparison and what investors can monitor next on Univest.

Table of Contents

SENORES PHARMACEUTICALS L (SENORES) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,244.4
Previous Close	Rs 1,324.05
Today's Move	-Rs 79.65 (-6.02%)
Open	Rs 1,328.75
High	Rs 1,339.5
Low	Rs 1,228.25
Market Capitalisation	Rs 6,034.4 crore
Market Cap Category	Mid Cap

The Senores Pharmaceuticals share price today reflects a sharp intraday decline. The stock opened at Rs 1,328.75, above the previous close of Rs 1,324.05, and moved as high as Rs 1,339.50 before reversing. It then slipped to a low of Rs 1,228.25 and was last traded at Rs 1,244.40 as of 29 October 2026 at 2:37:47 PM IST.

Measured against the previous close, the day change stands at Rs 79.65, a fall of 6.02%. Measured against the opening price, the stock is trading Rs 84.35 lower, and the gap between the day high and the day low is Rs 111.25. These figures show that the Senores Pharmaceuticals share price fall developed after a firm start rather than from the opening bell.

The company's market capitalisation of Rs 6,034.40 crore keeps it in the Mid Cap category, and that size context matters when reading a move of this scale. The decline is confirmed by the price data itself. The fundamentals and benchmarks in the next sections show how the stock now sits against its own financial ratios and its industry group.

Why Senores Pharmaceuticals (SENORES) May Be Moving Today

According to recent news reports, there are five items on the company, all dated 29 Oct. At 02:00 pm, it approved a Rs 43 crore expansion plan for its subsidiaries, including a new prefilled syringe line due by March 2027. At 01:55 pm, Q2 EBITDA was reported at 576 million rupees against 417 million rupees a year earlier, with the margin at 29.98% against 27.1%. At 01:54 pm, it projected 30-40% revenue growth and 50-60% PAT growth for fiscal year 2027. At 01:53 pm, Q2 revenue was reported at 1.9 billion rupees against 1.6 billion rupees, and Q2 consolidated net profit at 390 million rupees against 330 million rupees. These items were reported on the same day as the price fall, and the market data on its own does not establish a single confirmed cause.

SENORES PHARMACEUTICALS L (SENORES) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 6,034.4 crore
P/E Ratio	48.25x
P/B Ratio	6.33x
ROE	14.14%
ROCE	15.66%
EPS	Rs 27.44
Book Value Per Share	Rs 209.27
Dividend Yield	0%

SENORES PHARMACEUTICALS L (SENORES) fundamental metrics show P/E 48.25x, P/B 6.33x, ROE 14.14%, ROCE 15.66%. Read together, these ratios describe the company's position rather than a recommendation.

SENORES PHARMACEUTICALS L has a market capitalisation of Rs 6,034.40 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 48.25x, P/B at 6.33x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.14% and ROCE of 15.66%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 27.44, book value per share of Rs 209.27, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.57x, median ROE of 11.23%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	48.25x
Benchmark Median P/E	31.57x
Benchmark Average P/E	46.23x
Benchmark P/E Range	3.21x to 598.47x
Company P/B Ratio	6.33x
Benchmark Median P/B	2.75x
Benchmark Average P/B	4.02x
Company ROE	14.14%
Benchmark Median ROE	11.23%
Benchmark Average ROE	9.77%
Company ROCE	15.66%
Benchmark Median ROCE	13.1%
Benchmark Average ROCE	12.73%
Company Market Capitalisation	Rs 6,034.4 crore
Benchmark Median Market Cap	Rs 715.8 crore
Benchmark Average Market Cap	Rs 13,817.44 crore

SENORES PHARMACEUTICALS L (SENORES) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

SENORES PHARMACEUTICALS L (SENORES) has a P/E ratio of 48.25x, which is above the benchmark median of 31.57x, a difference of +52.83%. The P/E comparison frames valuation; it is not a signal to buy or sell.

SENORES PHARMACEUTICALS L (SENORES) has a ROE of 14.14%, which is above the benchmark median of 11.23%, a difference of +25.91%. SENORES PHARMACEUTICALS L (SENORES) has a ROCE of 15.66%, which is above the benchmark median of 13.1%, a difference of +19.54%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,22,282.95	34.87	4.88	14.85	19.11
Divi's Laboratories	DIVISLAB	2,51,611.12	86.78	14.37	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,75,182.22	81.67	9.44	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,16,408.7	25.9	4.34	19.69	21.39
Laurus Labs	LAURUSLABS	1,15,616.01	107.97	20.94	18.31	18.2

SENORES PHARMACEUTICALS L (SENORES) has a P/E ratio of 48.25x compared with the displayed peer median of 81.67x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 14.14% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 15.66% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. SENORES PHARMACEUTICALS L (SENORES) has a market capitalisation of Rs 6,034.4 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Senores Pharmaceuticals

The stock fell 6.02% to Rs 1,244.40 from a previous close of Rs 1,324.05.
The day range runs from Rs 1,228.25 to Rs 1,339.50, after an opening price of Rs 1,328.75.
The P/E of 48.25 sits above the same-industry median of 31.57 and the average of 46.23.
ROE of 14.14% and ROCE of 15.66% both sit above their benchmark medians of 11.23% and 13.10%.
Market capitalisation of Rs 6,034.40 crore is above the benchmark median of Rs 715.80 crore.

About Senores Pharmaceuticals

Senores Pharmaceuticals, trading under the symbol SENORES, is a Mid Cap company in the Healthcare sector. Its industry classification is Pharmaceuticals and Drugs, a group of 199 listed companies ranging from Rs 5.10 crore to Rs 4,22,282.95 crore in market capitalisation. With Rs 6,034.40 crore of market value, it sits well above the median of that group by size.

Track Senores Pharmaceuticals Share Price on Univest

Use SENORES PHARMACEUTICALS L (SENORES) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Investors who want to follow the Senores Pharmaceuticals share price can track the live price, key fundamental ratios, 52-week levels and market insights on Univest. The Univest stock page brings P/E, P/B, ROE, ROCE, EPS and book value together in one place, so the day's price action can be read against the company's financial profile and its Pharmaceuticals and Drugs peers.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is the Senores Pharmaceuticals share price today?

Ans. The Senores Pharmaceuticals share price was last traded at Rs 1,244.40 as of 29 October 2026 at 2:37:47 PM IST, down Rs 79.65 or 6.02% from the previous close of Rs 1,324.05.

Why is the Senores Pharmaceuticals share price falling today?

Ans. According to Univest data, the price fall of 6.02% is confirmed. The stock opened at Rs 1,328.75, touched a high of Rs 1,339.50 and then declined to a low of Rs 1,228.25 before trading at Rs 1,244.40.

What is the market capitalisation of Senores Pharmaceuticals?

Ans. Senores Pharmaceuticals has a market capitalisation of Rs 6,034.40 crore and is classed as a Mid Cap. Market capitalisation shows company size and does not indicate the quality of the business.

What are the day high and day low for the stock?

Ans. The stock touched a day high of Rs 1,339.50 and a day low of Rs 1,228.25. It opened at Rs 1,328.75 and is now at Rs 1,244.40, a gap of Rs 111.25 between high and low.

What is the P/E ratio of Senores Pharmaceuticals?

Ans. The P/E ratio is 48.25. In the same-industry benchmark of 199 companies, the median P/E is 31.57 and the average is 46.23, so the company sits above both the median and the average.

What are the ROE and ROCE of Senores Pharmaceuticals?

Ans. ROE is 14.14% and ROCE is 15.66%. ROE measures the return on shareholder equity, while ROCE measures the return on capital employed. Both sit above the benchmark medians of 11.23% and 13.10%.

What are the EPS and book value of Senores Pharmaceuticals?

Ans. Earnings per share are Rs 27.44 and book value is Rs 209.27 per share. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.

Does Senores Pharmaceuticals pay a dividend?

Ans. The dividend yield is 0.00%, so the stock shows no historical payout relative to the current price of Rs 1,244.40. Dividend yield is historical data and does not promise a future payout.

How does Senores Pharmaceuticals compare with its peers?

Ans. Among five large Pharmaceuticals and Drugs peers, it has a far smaller market capitalisation at Rs 6,034.40 crore. Its P/E of 48.25 is higher than two of the five peers and lower than the other three.